These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1140 related articles for article (PubMed ID: 26317652)

  • 1. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence
    Ding M; Bu X; Li Z; Xu H; Feng L; Hu J; Wei X; Gao J; Tao Y; Cai B; Liu Y; Qu X; Shen L
    Int J Biol Sci; 2020; 16(16):3100-3115. PubMed ID: 33162818
    [No Abstract]   [Full Text] [Related]  

  • 3. N-Myc downstream-regulated gene 2 restrains glycolysis and glutaminolysis in clear cell renal cell carcinoma.
    Shi W; Xu X; Yan F; Wang B; Zhao H; Chan A; Ren Z; Ma Y; Wang F; Yuan J
    Oncol Lett; 2017 Dec; 14(6):6881-6887. PubMed ID: 29163707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis.
    Fang Y; Shen ZY; Zhan YZ; Feng XC; Chen KL; Li YS; Deng HJ; Pan SM; Wu DH; Ding Y
    Nat Commun; 2019 Sep; 10(1):3981. PubMed ID: 31484922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
    Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T
    Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
    Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
    Li C; Wang P; Du J; Chen J; Liu W; Ye K
    IUBMB Life; 2021 Jan; 73(1):286-298. PubMed ID: 33314669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
    Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
    Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells.
    Straus DS
    Mol Cancer; 2013 Jul; 12():78. PubMed ID: 23866118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer.
    Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W
    Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
    Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
    Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells.
    Pérez-Escuredo J; Dadhich RK; Dhup S; Cacace A; Van Hée VF; De Saedeleer CJ; Sboarina M; Rodriguez F; Fontenille MJ; Brisson L; Porporato PE; Sonveaux P
    Cell Cycle; 2016; 15(1):72-83. PubMed ID: 26636483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.
    Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G
    Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells.
    Hu M; Liu L; Yao W
    Gene; 2018 Dec; 678():261-269. PubMed ID: 30103008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.
    Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X
    Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
    FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance.
    Ganguly K; Bhatia R; Rauth S; Kisling A; Atri P; Thompson C; Vengoji R; Ram Krishn S; Shinde D; Thomas V; Kaur S; Mallya K; Cox JL; Kumar S; Batra SK
    Gastroenterology; 2022 Jan; 162(1):253-268.e13. PubMed ID: 34534538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal Cancer Cell Differentiation Is Dependent on the Repression of Aerobic Glycolysis by NDRG2-TXNIP Axis.
    Hu J; Feng L; Ren M; Zhao Y; Lu G; Lu X; Li Y; Wang X; Bu X; Wang S; Shen L; He S
    Dig Dis Sci; 2022 Aug; 67(8):3763-3772. PubMed ID: 34373985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.
    Kim YJ; Yoon SY; Kim JT; Song EY; Lee HG; Son HJ; Kim SY; Cho D; Choi I; Kim JH; Kim JW
    Carcinogenesis; 2009 Apr; 30(4):598-605. PubMed ID: 19237607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.